KALAMAZOO, Michigan, USA, May 2, 2023 /PRNewswire/ — Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today that it has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and […]
Tag: Cerus Endovascular
Cerus Endovascular Names Stephen Griffin as Chief Executive Officer
FREMONT, Calif. and OXFORD, United Kingdom, July 12, 2022 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today the appointment of Stephen Griffin, Ph.D. to Chief Executive Officer, effective immediately. Dr. Griffin has been with the company since 2014 and […]
Cerus Endovascular Receives U.S. Food and Drug Administration 510(k) Clearance of its 027 Micro-catheter
– Company Announces Expansion of its Contour Neurovascular System™ Platform – FREMONT, Calif. and OXFORD, England, March 23, 2022 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) […]
Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System™
Patient Enrollment to Begin Within Three Months FREMONT, Calif. and OXFORD, United Kingdom, April 21, 2021 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption […]
Cerus Endovascular Announces the First Ever Robotic Assist Intracranial Implant of its Contour Intrasaccular Device
Groundbreaking Aneurysm Procedure Completed in 28 Minutes FREMONT, Calif. and OXFORD, United Kingdom, Dec. 17, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced the first ever robotically assisted intracranial implant of its Contour intrasaccular device. The groundbreaking procedure was […]
Cerus Endovascular and Balt Enter Strategic Distribution Agreement for Innovative Neurovascular Devices to Treat a Range of Intracranial Aneurysms
Balt to Commercialize Cerus Endovascular’s Contour Neurovascular System™ and Neqstent Coil Assisted Flow Diverter in Germany FREMONT, Calif. and OXFORD, United Kingdom and MONTMORENCY, France, Aug. 4, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company and AB Medica Deutschland Verwaltungs GmbH, a wholly owned […]
Cerus Endovascular Receives CE Mark Approval for its 021 Contour Neurovascular System™
Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, England, April 29, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its […]
Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms
Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, United Kingdom, April 22, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for […]
Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms
Commercial Sales Across European Union Expected to Begin in Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 18, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its […]
Cerus Endovascular Promotes Stephen Griffin, PhD, to President
FREMONT, Calif. and OXFORD, England, May 11, 2018 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems for the treatment of acute, life-threatening neurological conditions, […]